[A study of bone mineral density in postmenopausal and senile osteoporosis with vertebral fractures in female].
نویسنده
چکیده
Bone mineral density of the lumbar vertebrae (L2-4BMD) in involutional osteoporosis was measured by dual photon absorptiometry to investigate its relationship with the incidence of osteoporotic vertebral fractures of the thoracic and lumbar spine. In addition to monitor L2-4BMD, the author also examined the progress of vertebral fractures during drug treatments by means of radiographs. L2-4BMD at the antero-posterior projection was measured in 287 female subjects with involutional osteoporosis ranging from 45 to 91 years of age. Fracture of the vertebrae was determined from lateral radiographs. Low BMD is the most important risk factor in vertebrae fractures. There was a significant difference in L2-4BMD with and without fractures of the vertebrae. L2-4BMD for threshold was 0.633 g/cm2 for 90th percentile with vertebral fractures, and that for breakpoint was 0.532 g/cm2 for 65th percentile with vertebral fractures. The incidence of vertebral fractures with BMD above the threshold was 17.5%, however that between the threshold and the breakpoint was 30.6%. Furthermore that below the breakpoint was 48.9%. Although the incidence of vertebral fractures was affected to some extent by age, height, and weight, the number of vertebral fractures increased with the decrease of L2-4BMD. The progress of vertebral fractures under drug treatments with 1,25-dihydroxyvitamin D3, ipriflavone, and calcitonin was affected by pre-existing vertebral fractures and L2-4BMD at the first visit. Estimation of L2-4BMD and the existence of vertebral fractures is important in predicting new vertebral fractures and the further collapse of pre-existing vertebral fractures.
منابع مشابه
Evaluation of Frequency Pattern of Risk Factors for Decreased Bone Mineral Density in Postmenopausal Women Referred to the Bone Mineral Density Assessment Center of Al-Zahra Hospital in Isfahan during Years 2018 and 2019
Introduction: Osteoporosis is a systemic skeletal disease in which the internal structure and ability of bone to repair its daily damage is impaired. Menopause is a vital period that affects bone health, causing rapid loss of bone mass, which in turn increases the risk of fractures in postmenopausal women. The present study was performed to evaluate the frequency pattern of risk factors for dec...
متن کاملOsteoporosis and Osteoporotic Fractures in Postmenopausal Women with Type 2 Diabetes Compared with Non-Diabetic Cases
Objective: Correlation of osteoporosis (OP) with type 2diabetes mellitus (DM) , is not as clear as type 1 DM. The purpose of this study was to compare the frequency of OP and osteoporotic fractures in post- menopausal women with and without type 2 DM in Sari, Iran. Materials and Methods: Eighty post-menopausal women with type 2 DM and 80 non-diabetic controls enrolled in this study. Bone mine...
متن کاملProtective effects of pomegranate seed oil on ovariectomized rats as a model of postmenopausal osteoporosis: A multi-detector computed tomography evaluation
The pomegranate seed oil (PSO), containing 17-α-estradiol, is one of the newly found phytosterols with synergistic health effects on estrogen related physiological conditions. Herein, PSO was assessed for its potential improving effects on bone characteristics in a rat model of menopausal syndrome. Three month old non-pregnant female Wistar rats (n = 30) were either sham-operated (SHAM) or ovar...
متن کاملTeriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review.
CONTEXT AND OBJECTIVE Osteoporosis is defined as a disease characterized by low bone mass and deterioration of the bone tissue microarchitecture. Teriparatide stimulates the formation and action of osteoblasts, which are responsible for bone formation, thus promoting bone tissue increase. The aim was to assess the effectiveness and safety of teriparatide for treating postmenopausal osteoporosis...
متن کاملMenatetrenone (vitamin K2) and bone quality in the treatment of postmenopausal osteoporosis.
Menatetrenone (vitamin K2) reduces the incidence of vertebral fractures but has only modest effects on bone mineral density (BMD) in postmenopausal women with osteoporosis. Combined treatment with bisphosphonates and menatetrenone may be more effective than treatment with bisphosphonates alone in preventing vertebral fractures, despite the lack of an additive effect of menatetrenone on the BMD ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Nihon Ika Daigaku zasshi
دوره 61 3 شماره
صفحات -
تاریخ انتشار 1994